Mutant protein A (Protein A) affinity chromatography medium

A chromatographic medium and mutant protein technology, which is applied in the field of biomedicine, can solve problems such as inability to withstand high-concentration NaOH cleaning, gaps in alkali resistance, and poor column packing repeatability, achieving good column packing repeatability, greatly improving, The effect of structural stability

Inactive Publication Date: 2018-11-30
江苏珐玛赛谱生物科技有限公司
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, GE's MabSelect SuRe, whose matrix is ​​highly cross-linked agarose microspheres, has the advantages of excellent hydrophilicity and good biocompatibility, which is very suitable for the separation and purification of antibody biomacromolecules; but the disadvantages are: first, The structure is soft, the particle size distribution is wide, and there are problems such as poor packing repeatability and low mechanical strength in the actual use process; second, Mabselect Sure is generally cleaned with 0.1M NaOH in biopharmaceuticals, and its alkali resistance performance still has a gap ; Thirdly, the dynamic loading capacity of MabSelect Sure is >30g / L, and there is still a little gap in the demand for large-scale antibody production
However, a fatal flaw in the structure of glass beads is that it cannot withstand the gold standard of high-concentration NaOH cleaning, which limits its application in large-scale biological samples.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mutant protein A (Protein A) affinity chromatography medium
  • Mutant protein A (Protein A) affinity chromatography medium

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0023] A mutein A (Protein A) affinity chromatography medium, the mutein A (Protein A) affinity chromatography medium is used as a chromatography medium in the separation and purification of antibodies and Fc fusion proteins; the protein A ( Protein A) Affinity chromatography media are based on microspheres containing vinyl monomers, agarose or dextran gels. Suitable vinyl-containing monomers include, but are not limited to vinyl known to be used in polymerization processes Monomers, typical vinyl monomers include: styrene, methylstyrene, all isomers of vinyltoluene, and p-vinyltoluene, all isomers of ethylstyrene, propylstyrene, ethylene Naphthalene, vinylanthracene, and mixtures thereof. Vinyl monomers can also be combined with other copolymerizable monomers. Examples of such monomers include, but are not limited to, alkenonitrile and acrylate monomers, such as acrylonitrile, methacrylonitrile, acrylates, methacrylates, and mixtures thereof.

[0024] The microspheres of th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
pore sizeaaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a mutant protein A (Protein A) affinity chromatography medium, and the mutant protein A (Protein A) affinity chromatography medium as a chromatographic medium is used for separation and purification of antibodies and Fc fusion proteins. The mutant protein A (Protein A) affinity chromatography medium is prepared by modifying with a hydrophilic dendritic macromolecule, activating, coupling with a protein A (Protein A) ligand and capping based on genetically-engineered-modified Staphylococcus A protein, agarose or dextran gel microspheres. The modified protein A chromatographic medium has stable structure, moderate hardness, and a particle size distribution within a certain range. Therefore, modified protein A chromatographic medium has has good repeatability, high mechanical strength, greatly-improved flow rate, low cost, and large size when used in column loading, and is suitable for large-scale wide industrialization use.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to a mutein A (Protein A) affinity chromatography medium. Background technique [0002] In recent years, antibody drugs have developed rapidly. In 2018, 6 of the top 10 drugs in global sales were antibody drugs, and the top 5 were all antibody drugs. The purification of antibody drugs usually adopts the classic three-step or two-step chromatography method, while the protein A (Protein A) affinity medium uses the unique and specific adsorption ability of multiple regions on the protein A (Protein A) ligand for the Fc segment of the antibody , can be used as an antibody capture step, a one-step process can remove most of the impurities in the cell fermentation broth, and the purity can reach more than 99%. With the development of antibody drugs, the affinity chromatography media used for antibody capture has also achieved rapid development. [0003] However, protein A (Protein ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): B01J20/26B01J20/30B01D15/38
CPCB01D15/3804B01J20/24B01J20/26
Inventor 樊丰林
Owner 江苏珐玛赛谱生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products